Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	81.88	80.11	58.76	71.68	85.96	229.59
Short-Term Investments	13.68	62.23	95.66	85.83	63.54	147.32
Cash & Short-Term Investments	95.56	142.33	154.42	157.51	149.5	376.91
Cash Growth	-35.31%	-7.83%	-1.96%	5.35%	-60.34%	-7.92%
Accounts Receivable	117.89	105.2	88.72	94.89	55.39	62.52
Other Receivables	8.15	4.34	7.43	11.29	5.06	12.41
Total Trade Receivables	126.04	109.54	96.15	106.18	60.44	74.93
Inventory	144.4	102.7	91.83	92.49	72.4	56.51
Other Current Assets	34.7	42.25	22.71	39.45	22.63	43.76
Total Current Assets	400.7	396.81	365.12	395.62	304.97	552.1
Net Property, Plant & Equipment	21.78	20.02	17.86	22.63	31.39	27.7
Other Intangible Assets	377.42	283.61	289.96	338.78	350.3	156.55
Goodwill	92.24	86.48	79.84	82.27	75.4	77.73
Long-Term Investments	71.91	103.43	120.02	158.02	178.95	174.84
Other Long-Term Assets	84.54	73.45	72.69	57.51	50.88	50.76
Total Assets	1,049	963.8	945.49	1,055	991.89	1,040
Accounts Payable	112.85	78.35	85.37	106.06	65.31	44.51
Short-Term Debt	17.81	17.49	17.85	17.67	26.66	51.77
Current Portion of Leases	3.74	2.64	1.73	2.58	1.61	1.88
Other Current Liabilities	18.28	12.78	9.09	15.01	11.72	15.9
Total Current Liabilities	152.68	111.25	114.03	141.32	105.3	114.06
Long-Term Debt	78.74	25.9	44.02	52.4	9.27	-
Long-Term Leases	5.96	3.43	5.5	5.05	3.42	2.54
Other Long-Term Liabilities	44.41	28.11	35.08	30.21	31.89	36.83
Total Long-Term Liabilities	129.11	57.44	84.59	87.66	44.57	39.38
Total Liabilities	281.78	168.69	198.62	228.98	149.87	153.44
Common Stock	532.79	534.27	540.05	599.06	628.85	694.35
Additional Paid-in Capital	29.52	25.83	26.11	23.78	21.89	18.85
Accumulated Other Comprehensive Income	64.06	80.22	29.83	41.27	-0.38	-1.5
Retained Earnings	140.42	154.79	150.89	161.76	191.65	174.55
Total Common Shareholders' Equity	766.79	795.11	746.87	825.86	842.02	886.24
Shareholders' Equity	766.79	795.11	746.87	825.86	842.02	886.24
Total Liabilities & Equity	1,049	963.8	945.49	1,055	991.89	1,040
Total Debt	106.24	49.46	69.09	77.7	40.96	56.19
Net Cash (Debt)	-10.68	92.87	85.33	79.81	108.54	320.72
Net Cash Growth	-	8.84%	6.92%	-26.48%	-66.16%	-7.61%
Net Cash Per Share	-0.11	0.92	0.79	0.69	0.87	2.43
Book Value	766.79	795.11	746.87	825.86	842.02	886.24
Book Value Per Share	7.66	7.84	6.95	7.19	6.76	6.71
Tangible Book Value	297.14	425.02	377.07	404.8	416.32	651.97
Tangible Book Value Per Share	2.97	4.19	3.51	3.52	3.34	4.94

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.